[CYCC] YoY Quarter Result on 31-Mar-2013 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- 35.31%
YoY- -4.30%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 139 512 396 212 161 192 271 -10.52%
PBT -3,534 -5,675 -5,446 -3,356 -3,123 -4,779 -5,244 -6.36%
Tax -493 -763 -569 -258 -168 -191 -133 24.37%
NP -3,041 -4,912 -4,869 -3,082 -2,955 -4,588 -5,111 -8.28%
Tax Rate - - - - - - - -
Total Cost 3,180 5,424 5,265 3,294 3,116 4,780 5,382 -8.38%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin -2,187.77 -959.38 -1,229.55 -1,453.77 -1,835.40 -2,389.58 -1,885.98 2.50%
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS -20.51 -45.23 -59.83 -75.55 -90.66 -165.51 -270.70 -34.92%
EPS Diluted -20.51 -45.23 -59.83 -75.55 -90.66 -165.51 -270.70 -34.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.